Outcome Measurements Used in Randomized Controlled Trials of Teledermatology: A Systematic Mapping Review
- Authors:
- Chow, A., Soon, C., Smith, H. E., and Apfelbacher, C. J.
- Abstract:
- Assessment of the effectiveness of teledermatology has been hampered by the variety of outcome measures used, limiting the possibility for meta-analysis. This systematic mapping review classified the outcome measurement instruments used in randomized controlled trials of teledermatology conducted between 2008 and 2018 using the Core Outcome Measures in Effectiveness Trials taxonomy. Sixteen articles describing 12 studies were identified. Each trial used a mean of 3.7 outcome measurements (range 2-7) , with a total of 55 different instruments employed. Most instruments mapped on the "skin and subcutaneous tissue outcomes" domain. The most frequently used instrument (Dermatology Life Quality Index) was used in only 3 studies. Over 60% of the instruments used did not cite any evidence of validation. This mapping review provides a list of outcome measurement instruments that can be used as a resource when designing teledermatology trials in the future and provides the foundation for the development of a core outcome set.
- DOI:
- 10.2340/00015555-3312
- Journal:
- Acta Derm Venereol
- issn:
- 0001-5555
- Publication year:
- 2019
- pages:
- Biological and physiological variables:
- Biological and physiological variables
- Symptom status:
- Physical state
- General health perceptions / HRQoL:
- Self-rated health
- Age:
- Adults (18-65)
Children (0-18) - Disease:
- Diseases of and symptoms related to the skin and subcutaneous tissue
- PRO / non-PRO:
- Non-patient Reported Outcome
Patient Reported Outcome - Type of measurement instrument:
- 1 - Questionnaires
3 - Diaries
6 - Clinical rating scales
7 - Observations - Instrument:
- 15 item satisfaction questionnaire
2D photography
Burke and Cunliffe Leeds technique
CDLQI - Childrens' Dermatology Life Quality Index
Diary
DLQI - Dermatology Life Quality Index
FILC - Frontal Inflammatory Lesion Count
Forced choice
Global Acne Severity Scale
HLQ - Health and Labor Questionnaire (versions: HLQ-SF)
IDQoL - Infant’s Dermatitis Quality of Life Index
IGA - Investigators Global Assessment Scale (versions: 5-point IGA; 6-point IGA; 7-point IGA)
ISDL - Impact of Chronic Skin Disease on Daily Life
PASI - Psoriasis Area and Severity Index
PBI - Patient Benefit Index (Pt Benefit Form) (versions: PBI-PAD; PBI-Allergic Rhinitis; PBI-M; PBI-Lymphedema)
PGA - Physician Global Assessment
POEM - Patient-Oriented Eczema Measure (versions: POEM in Children; POEM in Adolscents)
PSQ II / III - Patient Satisfaction Questionnaire II / III
SCORAD - SCOring Atopic Dermatitis index (versions: SCORAD-Subjective; oSCORAD - objectieve SCORAD; SCORAD-physician; PO-SCORAD - Patient Oriented SCORAD)
SF-12 - 12-item Short Form Health Survey [alias: RAND-12] (versions: SF-12v2; VR-12 - Veterans SF-12; SF-12 MCS; SF-12 PCS)
Skindex-16
Stopwatch
TILC - Total Inflammatory Lesion Count
Total lesion counting
VAS-itch - Visual analogue scale (VAS) measuring the itch intensity